147 related articles for article (PubMed ID: 25413596)
21. Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents.
Hevener KE; Ball DM; Buolamwini JK; Lee RE
Bioorg Med Chem; 2008 Sep; 16(17):8042-53. PubMed ID: 18701298
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.
Khunt RC; Khedkar VM; Chawda RS; Chauhan NA; Parikh AR; Coutinho EC
Bioorg Med Chem Lett; 2012 Jan; 22(1):666-78. PubMed ID: 22104148
[TBL] [Abstract][Full Text] [Related]
23. Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.
Pancholia S; Dhameliya TM; Shah P; Jadhavar PS; Sridevi JP; Yogeshwari P; Sriram D; Chakraborti AK
Eur J Med Chem; 2016 Jun; 116():187-199. PubMed ID: 27061982
[TBL] [Abstract][Full Text] [Related]
24. A Structure-Activity Relationship Study of Naphthoquinone Derivatives as Antitubercular Agents Using Molecular Modeling Techniques.
Sharma MC
Interdiscip Sci; 2015 Dec; 7(4):346-56. PubMed ID: 26159131
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
26. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
27. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
Saxena AK; Alam M
Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
[TBL] [Abstract][Full Text] [Related]
28. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
Puratchikody A; Natarajan R; Jayapal M; Doble M
Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
[TBL] [Abstract][Full Text] [Related]
30. Insight into the structural requirements of aminopyrimidine derivatives for good potency against both purified enzyme and whole cells of M. tuberculosis: combination of HQSAR, CoMSIA, and MD simulation studies.
Punkvang A; Hannongbua S; Saparpakorn P; Pungpo P
J Biomol Struct Dyn; 2016 May; 34(5):1079-91. PubMed ID: 26156406
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and binary QSAR study of antitubercular quinolylhydrazides.
Manvar A; Khedkar V; Patel J; Vora V; Dodia N; Patel G; Coutinho E; Shah A
Bioorg Med Chem Lett; 2013 Sep; 23(17):4896-902. PubMed ID: 23876988
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.
Desai B; Sureja D; Naliapara Y; Shah A; Saxena AK
Bioorg Med Chem; 2001 Aug; 9(8):1993-8. PubMed ID: 11504636
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in QSAR-based identification and design of anti-tubercular agents.
Nidhi ; Siddiqi MI
Curr Pharm Des; 2014; 20(27):4418-26. PubMed ID: 24245761
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides.
Manvar A; Malde A; Verma J; Virsodia V; Mishra A; Upadhyay K; Acharya H; Coutinho E; Shah A
Eur J Med Chem; 2008 Nov; 43(11):2395-403. PubMed ID: 18328603
[TBL] [Abstract][Full Text] [Related]
35. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents.
Cihan-Üstündağ G; Şatana D; Özhan G; Çapan G
J Enzyme Inhib Med Chem; 2016; 31(3):369-80. PubMed ID: 25910087
[TBL] [Abstract][Full Text] [Related]
36. Antitubercular properties of thiazolidin-4-ones - A review.
Trotsko N
Eur J Med Chem; 2021 Apr; 215():113266. PubMed ID: 33588179
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.
Macaev F; Rusu G; Pogrebnoi S; Gudima A; Stingaci E; Vlad L; Shvets N; Kandemirli F; Dimoglo A; Reynolds R
Bioorg Med Chem; 2005 Aug; 13(16):4842-50. PubMed ID: 15993090
[TBL] [Abstract][Full Text] [Related]
38. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
39. Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agents.
Friggeri L; Ballante F; Ragno R; Musmuca I; De Vita D; Manetti F; Biava M; Scipione L; Di Santo R; Costi R; Feroci M; Tortorella S
J Chem Inf Model; 2013 Jun; 53(6):1463-74. PubMed ID: 23617317
[TBL] [Abstract][Full Text] [Related]
40. In silico Studies, Synthesis and Antitubercular Activity of Some Novel Quinoline - Azitidinone Derivatives.
Chitre TS; Asgaonkar KD; Vikhe AB; Patil SM; Garud DR; Khedkar VM; Sarkar D; Nawale LU; Yeware A
Curr Comput Aided Drug Des; 2021; 17(1):134-143. PubMed ID: 31995017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
